Mitochondrial DNA Content May Not Be a Reliable Screening Biomarker for Live Birth After Single Euploid Blastocyst Transfer.
Mitochondrial DNA Content May Not Be a Reliable Screening Biomarker for Live Birth After Single Euploid Blastocyst Transfer.
复制标题
线粒体 DNA 含量可能不是单倍体囊胚移植后活产的可靠筛选生物标志物
DOI:
10.3389/fendo.2021.762976
复制
发表时间:
2021
影响因子:
5.2
通讯作者:
Xu C
中科院分区:
文献类型:
--
作者:
Zhou X;Liu X;Shi W;Ye M;Chen S;Xu C
An increasing number of studies have related the mitochondrial DNA (mtDNA) content to embryo viability and transfer outcomes. However, previous studies have focused more on the relationship between mtDNA and embryo implantation, few studies have studied the effect of the mtDNA content on live birth. In the study, we investigated whether mtDNA content is a reliable screening biomarker for live birth after single blastocyst transfer. A total of 233 couples with 316 blastocyst stage embryos undergoing in vitro fertilization treatment and pre-implantation genetic testing analysis were included in the study. All embryos were chromosomally normal and had undergone single-embryo transfers. There was no significant difference observed in the blastocyst mtDNA content among the live birth, miscarriage and non-implanted groups (p=0.999), and the mtDNA content in blastocysts from the miscarriage and live birth groups was similar [median (interquartile range), 1.00*108(7.59*107- 1.39*108) vs 1.01*108 (7.37*107- 1.32*108)]. Similarly, no significant association was observed between mtDNA content and embryo implantation potential (p=0.965). After adjusting for multiple confounders in a logistic regression analysis with generalized estimating equations, no associations between mtDNA content and live birth were observed in all blastocysts, Day-5 and Day-6 blastocysts (p=0.567, p=0.673, p=0.165, respectively). The live birth rate was not significantly different between blastocysts with an elevated mtDNA content and blastocysts with a normal mtDNA content (26.7% vs 33.6% p=0.780). Additionally, there was no linear correlation between the mtDNA content and maternal age (p=0.570). In conclusion, the mtDNA content does not seem to be a potential biomarker for embryo transfer outcomes (i.e., implantation and live birth) based on the existing testing tools. Embryos with an elevated mtDNA content also have development potential for successful live birth.
登录
查看更多内容
影响因子:
4.5
作者:
Fragouli E;Spath K;Alfarawati S;Kaper F;Craig A;Michel CE;Kokocinski F;Cohen J;Munne S;Wells D
通讯作者:
Wells D
影响因子:
6.7
作者:
Fischer, Jill;Colls, Pere;Munne, Santiago
通讯作者:
Munne, Santiago
影响因子:
6.1
作者:
Fragouli, Elpida;McCaffrey, Caroline;Wells, Dagan
通讯作者:
Wells, Dagan
影响因子:
--
作者:
Kirillova, Anastasia;Lysenkov, Sergey;Sukhikh, Gennady
通讯作者:
Sukhikh, Gennady
DOI:
10.1042/bcj20190767
发表时间:
2020-11-13
期刊:
The Biochemical journal
影响因子:
--
作者:
Hock DH;Robinson DRL;Stroud DA
通讯作者:
Stroud DA